Jun 17, 2021 | ACA, News and Updates
On June 17, 2021, the Supreme Court issued its long-anticipated decision in California v. Texas, upholding the Affordable Care Act once again in a 7-2 ruling. The Court did not reach the merits of whether the now $0 individual mandate penalty rendered the law...
Jun 16, 2021 | 340B, Litigation, News and Updates
A district court judge in Delaware issued an opinion denying the government’s motion to dismiss a lawsuit regarding a December 2020 Advisory Opinion issued by the Health and Resource Service Administration (HRSA). The judge concluded that the 340B statute is silent as...
Jun 11, 2021 | COVID-19, News and Updates
On June 11, 2021 the Department of Health and Human Services (HHS) published revised Reporting Requirements for recipients of Provider Relief Fund (PFR) payments. Notably, these revisions have impacted when funds must be used and reporting deadlines for some tranches...
Jun 10, 2021 | 340B, Litigation, News and Updates
On June 10, 2021, Eli Lilly became the third manufacturer to response to HRSA’s May 17th Cease and Desist letter on 340B drug pricing. The response details Eli Lilly’s rejection of HRSA’s reasoning in its Cease and Desist letter, arguing that the agency’s reasoning is...
May 18, 2021 | 340B, Litigation, News and Updates
On May 17, 2021, the Health and Resource Service Administration (HRSA) issued letters to six pharmaceutical manufacturers requiring the entities to immediately cease an ongoing practice of withholding 340B pricing to covered entities utilizing contract pharmacies....
